WELL Health Technologies Corp.

WELL Health Technologies Corp.

2.58
USD
-0.11
(-4.14%)
-0.32EPS
819.89MMarket Cap
Mar 25Next Earn
WELL Health Technologies Corp.
OTC:WHTCF
(OTC Markets)

Recent

price

2.58

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CAD
- -
- -
- -
- -
- -
0.03
- -
0.25
0.34
0.38
1.58
2.58
3.28
3.73
5.54
6.12
Revenue per Share
- -
-0.01
-0.02
-0.01
-0.02
-0.06
-0.24
-0.1
-0.08
-0.03
-0.23
0.01
- -
0.13
-0.03
-0.5
Basic EPS, GAAP
- -
- -
-0.02
- -
-0.01
-0.05
-0.04
-0.05
-0.03
-0.05
0.1
0.32
0.25
-0.03
0.37
0.29
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.04
0.04
0.08
0.08
0.05
0.04
-0.02
- -
0.28
1.33
2.95
3.17
3.18
3.48
3.4
3.12
Book Value per Share
0.04
0.04
0.08
0.08
0.05
-0.02
-0.02
- -
0.06
0.51
-2.06
-1.46
-1.22
-1.09
-2.69
-3.37
Tangible Book Value per Share
5
5
5
7
7
10
23
23
97
134
191
221
237
247
253
255
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
6
33
50
302
569
776
920
1,400
1,561
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
-201.49
- -
-35.44
-18.55
-21.35
-2.82
4.21
4.45
-3.35
6.62
4.65
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
2
5
39
55
61
72
94
106
Depreciation Expense
- -
- -
- -
- -
- -
-1
-6
-2
-8
-4
-44
1
- -
33
-7
-129
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
14.67
- -
15.94
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
-205.68
- -
-38.26
-23.83
-7.41
-14.61
0.24
0.01
3.55
-0.53
-8.25
Profit Margin (%)
- -
- -
1
1
- -
- -
- -
- -
10
80
5
42
60
-36
12
209
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
18
20
345
343
402
397
488
847
LT Debt
- -
- -
1
1
- -
- -
-1
- -
32
218
708
815
846
930
1,039
1,049
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.45
- -
4.41
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.93
- -
1.89
- -
Return on Capital (%)
- -
-31.29
-33.77
-6.89
-33.96
-141.08
- -
- -
- -
-2.99
-10.59
0.2
0.01
3.99
-0.85
- -
Return on Common Equity (%)

Capital Structure

CAD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
123
132
64
LT Borrowings
483
620
770
LT Finance Leases
67
76
77
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
256
255
256
Market Capitalization
968
1,059
1,167

Working Capital

CAD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
379
388
484
Cash, Cash Equivalents & STI
134
131
217
Accounts Receivable, Net
181
187
207
Inventories
2
3
3
Total Current Liabilities
458
487
275
Payables & Accruals
103
168
115
ST Debt
123
132
64
Deferred Revenue
33
34
31

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
52.96%
11.8%
Free Cash Flow
-79.85%
-354.62%
-1,502.42%
Net Income, GAAP
4,172.07%
8,086.81%
-122.57%
Sales/Revenue/Turnover
- -
139.43%
52.25%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
223
227
234
193
920
2025
294
357
- -
385
1,400
2026
368
400
407
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.42
-0.39
-0.05
0.13
2025
-0.19
0.05
- -
0.09
-0.03
2026
-0.05
-0.04
-0.5
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
WELL Health Technologies Corp. (WELL.TO) operates as a practitioner-focused digital healthcare company, owning and operating Canada's largest network of outpatient medical clinics providing primary, allied, diagnostic, specialized, and preventative care services; in the United States, it delivers omni-channel patient services targeting medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. The company offers a comprehensive practitioner enablement platform, including electronic medical records (EMR) such as OSCAR, Juno, Profile (Intrahealth), and Cerebrum (AwareMD); telehealth platforms; practice management software; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions; cybersecurity and patient data privacy tools; digital health apps; ePharma; digital booking; e-Referral; and e-Rx services. Founded in 2010 and headquartered in Vancouver, British Columbia, Canada, WELL primarily serves healthcare providers and patients across Canada, the United States in 19 states, and internationally, supporting over 42,000 providers and tens of millions of patient interactions through its omni-channel model. In recent developments, WELL has accelerated its Canadian clinics acquisition strategy, completing 12 transactions year-to-date through Q3 2025 acquiring CAD 67 million in clinical revenue, surpassing prior-year full-year metrics, with a CAD 235 million pipeline under LOI across 61 clinics; it added over CAD 100 million in annualized revenue from seven cash acquisitions since December 2024. The company reorganized through intra-group transactions, including HealWell divesting polyclinic assets and its Neutro AI scribe platform to WELL Star, alongside forming a 50/50 clinical research joint venture with WELL; WELL Star acquired a healthcare billing company and advanced toward a go-public initiative targeting over CAD 100 million run-rate revenue. WELL continues strategic evaluation of divesting U.S. care delivery assets like Wisp, Circle Medical, and CRH, with multiple advanced discussions underway, while enhancing AI integration and clinic digitization for operational efficiency.

Company News

  • WELL Health Technologies Q3 Earnings Call Highlights

  • WELL Health Reports Record Q3-2026 Revenue; Canadian Patient Services Adjusted EBITDA Up 82%, Reaching $100 Million Annualized Run-Rate Milestone One Quarter Ahead of Plan

  • WELL Health to Announce Third Quarter 2026 Financial Results on November 9, 2026

  • HEALWELL and WELL Health Announce Competition Bureau has Concluded Its Merger Review and Issued a No Action Letter

  • WELL Health and HEALWELL Announce Competition Bureau Has Concluded Its Merger Review and Issued a No Action Letter

  • WELL Health Technologies (TSE:WELL) Stock Price Breaks Below 200-Day Moving Average – Here’s Why

  • WELL Health Strengthens Privacy and AI Governance Leadership with Appointment of Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory

  • WELL Health to Present at The Cantech Investment Conference on October 8 in Toronto

  • WELL Health Subsidiary WELLSTAR Announces Completion of Amalgamation and Expected Trading Date of "WSTR" on TSXV

  • WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement

  • WELL Health Launches WELL Research, an End-to-End Clinical Trial Platform Built on Canada's Largest Outpatient Network

  • WELL Health Announces Planned CFO Transition; Evelyn Sutherland Appointed Chief Financial Officer

  • WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents

  • HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients

  • WELL Health Redeems $70 Million 5.50% Convertible Debentures

  • WELL Health Technologies Q2 Earnings Call Highlights

  • WELL Health Achieves Record Quarterly Revenue Milestone of $400 Million in Q2-2026, Driven by 32% Revenue Growth of Canadian Patient Services, and Raises 2026 Annual Guidance

  • WELL Health Strengthens Executive Leadership Team with Appointments of Loreto Grimaldi as Chief Legal Officer and Kaytek Przybylski as Chief Digital & Information Officer

  • WELL Health to Announce Second Quarter 2026 Financial Results on August 6, 2026

  • WELL Health Subsidiary WELLSTAR Closes C$50 Million Financing Transaction Ahead of Planned TSXV Listing